# Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study

> **NCT01853787** · PHASE4 · COMPLETED · sponsor: **University of Milan** · enrollment: 49 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Formoterol Fumarate
- **DRUG:** Salmeterol

## Key facts

- **NCT ID:** NCT01853787
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2015-07-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01853787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01853787, "Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01853787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*